Eric Engels Appointed Acting Branch Chief
, by DCEG Staff
Eric Engels
In April 2017, Eric Engels, M.D., M.P.H., was appointed acting Chief of the Infections and Immunoepidemiology Branch (IIB). Dr. Engels is an international leader in research on cancer among immunosuppressed individuals, including persons with HIV and transplant recipients, and on the epidemiology of non-Hodgkin lymphoma. In addition, he has served as Chair of the DCEG Technical Evaluation of Protocols Committee and a member of the Senior Advisory Group since 2011.
Dr. Engels received his medical degree from Harvard Medical School and Master of Public Health degree from Tufts University School of Medicine. He joined DCEG in 1998 and was awarded scientific tenure by the NIH in 2007.
Dr. Engels takes over from Allan Hildesheim, Ph.D., who served as Chief for nine years. Dr. Hildesheim is looking forward to continuing as a senior investigator in the Branch, conducting research on nasopharyngeal cancer, cervical cancer, and HPV-based vaccination and screening.